|
|
|
|
||
Re: New CTD - Mechanics of the Process (February 1, 2016) I've said it before, although I have nothing to base it on. I think recruitment for combo will be easy. Combining an approved drug with a lot of hype (Keytruda) with a very promising new drug (PV-10) that has already shown potential synergy is a win/win for the patients needing treatment. Easy recommendation for doctors. The combo trial seems like it would be a lot easier to recruit for over the P3 trials where you run the risk of being put in the chemo arm of the trial. |
return to message board, top of board |